TYRA — Tyra Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Tyra Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -26.3 | -55.3 | -69.1 | -86.5 | -120 |
| Depreciation | |||||
| Non-Cash Items | 2.89 | 10.6 | 12.3 | 16.9 | 25.9 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.481 | -5.85 | 6.36 | -0.729 | -1.63 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -23.7 | -50.3 | -50.1 | -69.8 | -95.1 |
| Capital Expenditures | -0.661 | -0.559 | -0.77 | -0.664 | -0.141 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.016 | 0 | -144 | -97.7 | 72.6 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.645 | -0.559 | -145 | -98.4 | 72.5 |
| Financing Cash Flow Items | -0.025 | — | — | -0.42 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 311 | 0.632 | 1.54 | 202 | 8.1 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 287 | -50.2 | -193 | 34 | -14.6 |